Hyaluronic acid: A specific prognostic indicator of hepatic damage in biliary atresia

被引:30
作者
Kobayashi, H [1 ]
Horikoshi, K [1 ]
Yamataka, A [1 ]
Yamataka, T [1 ]
Okazaki, T [1 ]
Lane, GJ [1 ]
Miyano, T [1 ]
机构
[1] Juntendo Univ, Sch Med, Dept Pediat Surg, Bunkyo Ku, Tokyo 1138421, Japan
关键词
biliary atresia; hepatic sinusoidal endothelial cell; hyaluronic acid; factor VIII-related antigen;
D O I
10.1016/S0022-3468(99)90314-7
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Background/Purpose: Hepatic fibrosis can progress in biliary atresia (BA) and is associated with capillarization of hepatic sinusoids. The significance of serum hyaluronic acid (HA) as a noninvasive indicator of histological sinusoidal endothelial cell (SEC) damage and hepatic fibrosis in BA, is investigated. Methods: A total of 28 postoperative BA patients (mean age, 11.0 +/- 3.7 years) and 20 normal controls (mean age, 10.5 +/- 2.8 years) were studied. BA patients were divided into group I, good liver function (n = 8); group II, moderate liver dysfunction (n = 10); and group III, severe liver dysfunction (n = 10). Serum HA was determined using a one-step sandwich enzyme immunoassay, and liver histological damage was confirmed immunohistochemically using an antibody against factor VIII-related antigen (FVIIIRAg), which is specific for detecting damaged SEC. Results: Serum HA was significantly higher (P < .0001) in group III (84.8 +/- 80.5 ng/mL) than in group 1 (15.9 +/- 6.9 ng/mL) or group 11 (28.7 +/- 10.7 ng/mL). Although immunoreactive products of FVIIIRAg were abundant in group III, they were not detected in SEC from group II. Conclusion: Serum HA may be of value for monitoring postoperative BA patients as a noninvasive indicator of SEC damage and progressive hepatic fibrosis. J Pediatr Surg 34:1791-1794. Copyright (C) 1999 by W.B. Saunders Company.
引用
收藏
页码:1791 / 1794
页数:4
相关论文
共 16 条
[1]   SERUM HYALURONATE AS A MARKER OF HEPATIC DERANGEMENT IN ACUTE LIVER-DAMAGE [J].
BRAMLEY, PN ;
RATHBONE, BJ ;
FORBES, MA ;
COOPER, EH ;
LOSOWSKY, MS .
JOURNAL OF HEPATOLOGY, 1991, 13 (01) :8-13
[2]   ASSAY OF SERUM HYALURONIC-ACID IN CLINICAL-APPLICATION [J].
CHICHIBU, K ;
MATSUURA, T ;
SHICHIJO, S ;
YOKOYAMA, MM .
CLINICA CHIMICA ACTA, 1989, 181 (03) :317-323
[3]   Biliary atresia: The King's College Hospital experience (1974-1995) [J].
Davenport, M ;
Kerkar, N ;
MieliVergani, G ;
Mowat, AP ;
Howard, ER .
JOURNAL OF PEDIATRIC SURGERY, 1997, 32 (03) :479-485
[4]  
DEACIUC IV, 1993, HEPATOLOGY, V17, P266, DOI 10.1002/hep.1840170217
[5]  
FRASER JRE, 1985, CELL TISSUE RES, V242, P505
[6]   SERUM HYALURONATE IN LIVER-DISEASES - STUDY BY ENZYMOIMMUNOLOGICAL ASSAY [J].
FREBOURG, T ;
DELPECH, B ;
BERCOFF, E ;
SENANT, J ;
BERTRAND, P ;
DEUGNIER, Y ;
BOURREILLE, J .
HEPATOLOGY, 1986, 6 (03) :392-395
[7]   HEMODYNAMIC AND LIVER-FUNCTION PREDICTORS OF SERUM HYALURONAN IN ALCOHOLIC LIVER-DISEASE [J].
GIBSON, PR ;
FRASER, JRE ;
BROWN, TJ ;
FINCH, CF ;
JONES, PA ;
COLMAN, JC ;
DUDLEY, FJ .
HEPATOLOGY, 1992, 15 (06) :1054-1059
[8]  
HARRISON RL, 1989, LIVER, V9, P242
[9]   LIVER-TRANSPLANTATION AND KASAI OPERATION IN THE 1ST YEAR OF LIFE - THERAPEUTIC DILEMMA IN BILIARY ATRESIA [J].
LILLY, JR ;
HALL, RJ ;
ALTMAN, RP .
JOURNAL OF PEDIATRICS, 1987, 110 (04) :561-562
[10]   BIOCHEMICAL MARKERS OF HEPATIC-FIBROSIS [J].
PLEBANI, M ;
BURLINA, A .
CLINICAL BIOCHEMISTRY, 1991, 24 (03) :219-239